Totus Environmental Limited
Michelle Bolan has extensive experience in logistics and operations management, currently serving as the Service Delivery Team Leader and previously as Operations Coordinator at Totus Environmental Limited since March 2022. Prior roles include Shipping Specialist at Mini-Cam from January 2021 to March 2022, Export Logistics Manager at Heat Trace Limited between September 2017 and December 2020, and Transport Planner at CEMEX UK from April 2015 to August 2017. Michelle's career began as a Customer Service Specialist at E C Dewitt from September 2004 to August 2009, and includes a tenure at Medtrade Products Limited as Customer Logistics from September 2009 to April 2015. Educational qualifications include a degree in Business Management from Edge Hill University, attended from 2001 to 2004, following secondary education at Cowley High School from 1994 to 1999, with additional education at Cowley College and Cowley High School St Helens.
This person is not in any teams
Totus Environmental Limited
Totus Environmental is one of the UK’s leading providers of innovative international waste management solutions. Working with clients across the commercial, municipal and hazardous waste sectors we have developed an unrivalled network of recycling and recovery outlets. Our broad off-take network means that we can provide SRF and RDF producers with a consistent, cost effective and sustainable export solution for their fuel. The Company’s hazardous waste division works across a range of sectors and has over 20 years experience in delivering international recycling, recovery and disposal solutions for a wide variety of hazardous materials. Our asset tracking service provides our customers with full traceability for all their material down to a single bale or container. In addition to unrivalled management information and confidence this also enables us to consolidate partial loads. Totus’ international experience and partnerships empowers us to provide our customers with fully compliant alternatives to the UK market, where treatment options can often be limited both by capability and capacity.